Soligenix Receives IND Clearance from FDA to Init
Post# of 48
Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX203 as Therapy for Pediatric Crohn's Disease
http://www.otcmarkets.com/stock/SNGX/news
Soligenix Receives IND Clearance from FDA to Initiate Clinical Program to Evaluate SGX203 as Therapy for Pediatric Crohn's Disease
http://www.otcmarkets.com/stock/SNGX/news